From the Journals
Expert questions whether current guidance favoring total thyroidectomy goes too far.
Some of the experts who crafted the 2017 NAMS position statement on hormone therapy discuss the new messages for clinicians and the evidence to...
News for Your Practice
Considering new data, more than 20 experts offer consensus on hormone therapy benefits and risks overall and in special populations...
PHILADELPHIA – Dr. Kaunitz shares what he learned about migraines, breast imaging, and the connection between type 2 diabetes and the risk for...
Does extending aromatase-inhibitor use from 5 to 10 years benefit menopausal women with hormone-positive breast cancer?
In terms of improving the 5-year disease-free survival (DFS) rate, yes, according to results of a randomized study that compared extended...
PHILADELPHIA - Preliminary research shows GSM doesn’t always match up with women’s symptoms.
Recent trial results on the cardiovascular safety of hormone therapy in early menopausal women are reassuring, while survey data reveal millions...
PHILADELPHIA – The intervention was effective even for women with the highest depression scores.
A patient may skip talking about sexual function out of embarrassment, and a clinician out of concern for the patient’s feelings. We may be...
PHILADELPHIA – If approved, the new formulation could offer an option for women currently using compounded bioidenticals.